ANTX
AN2 Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.63 / 10
Underperform
Technically, ANTX is under pressure with a score of 1.63/10. Dominant bearish signals include repeated Long Upper Shadow patterns, a MACD Death Cross, and Marubozu White candles, all pointing to declining momentum and weak price action. The scarcity of bullish indicators underscores the need for patience until clearer reversal signals emerge.
Analysis Checks(0/3)
Long Upper Shadow
Score1.67/10
Win Rate41.46%
Hist. Signals41
Avg Return-0.10%
Score1.67/10
Win Rate41.46%
Hist. Signals41
Avg Return-0.10%
Marubozu White
Score1.7/10
Win Rate40.54%
Hist. Signals37
Avg Return0.23%
Score1.7/10
Win Rate40.54%
Hist. Signals37
Avg Return0.23%
MACD Death Cross
Score1.51/10
Win Rate40.00%
Hist. Signals10
Avg Return-1.32%
Score1.51/10
Win Rate40.00%
Hist. Signals10
Avg Return-1.32%
Long Upper Shadow
Score1.67/10
Win Rate41.46%
Hist. Signals41
Avg Return-0.10%
Score1.67/10
Win Rate41.46%
Hist. Signals41
Avg Return-0.10%
MACD Death Cross
Score1.51/10
Win Rate40.00%
Hist. Signals10
Avg Return-1.32%
Score1.51/10
Win Rate40.00%
Hist. Signals10
Avg Return-1.32%
Marubozu White
Score1.7/10
Win Rate40.54%
Hist. Signals37
Avg Return0.23%
Score1.7/10
Win Rate40.54%
Hist. Signals37
Avg Return0.23%
Technical Analysis of ANTX?
- ANTX presents a Underperform setup with a Technical Score of 1.63/10. Key technical indicators highlight an RSI of 43.44 and a MACD of -0.03, with the trend anchored by the 50-Day SMA at 1.14. Traders should monitor key support at 1.05 and resistance at 1.09.
